Marc Rubiralta (#2935)
- $ 1 B
- Diagnostics
- Spain
- M
- 42 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Marc Rubiralta chairs Werfen, one of Spain's largest diagnostics company based in Barcelona. He inherited his stake from his late father Josep María Rubiralta, who cofounded Werfen which later became a specialist in in vitro diagnostics. Since becoming chairman in 2019, one of his notable deals include the $2 billion acquisition of U.S.-based Immucor. His brothers Jordi, Luis and Xavier each own stakes in the company and are also billionaires. Rubiralta is also president of Monterri, the investment company he owns with José Luis and Xavier.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Marc Rubiralta’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Marc Rubiralta’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.3B
(May 4, 2026)
© Iconic Billionaires